Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Venous Thromboembolism Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06947707
What this trial is testing

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

Who this might be right for
Cerebral Venous ThrombosisAnticoagulants and Thrombotic DisordersAnticoagulation Treatment+6 more
Xuanwu Hospital, Beijing 1,486
Not applicableStudy completedNCT01305564
What this trial is testing

A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System

Who this might be right for
Pulmonary Embolism
C. R. Bard 200
Testing effectiveness (Phase 2)Study completedNCT03178864
What this trial is testing

Study of Rivaroxaban for CeREbral Venous Thrombosis

Who this might be right for
Cerebral Venous Thrombosis
University of British Columbia 55
Not applicableUnknownNCT05150314
What this trial is testing

Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin

Who this might be right for
Venous Thromboembolic Disease
University Hospital, Strasbourg, France 2,000
Post-approval studies (Phase 4)Looking for participantsNCT07303816
What this trial is testing

Statins to Prevent Cancer Associated Blood Clots

Who this might be right for
Venous ThromboembolismCancerCardiovascular Events
Brigham and Women's Hospital 4,000
Testing effectiveness (Phase 2)Study completedNCT02048865
What this trial is testing

Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients

Who this might be right for
Venous ThromboembolismCancer
Ottawa Hospital Research Institute 575
Not applicableUnknownNCT04519398
What this trial is testing

Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events

Who this might be right for
Covid19Corona Virus InfectionThrombosis+5 more
Grigore T. Popa University of Medicine and Pharmacy 60
Not applicableEnded earlyNCT01088334
What this trial is testing

Mortality Due to Malignancy in Patients With Idiopathic Venous Thromboembolism

Who this might be right for
Venous ThromboembolismMalignancy
Slotervaart Hospital 630
Not applicableStudy completedNCT04477837
What this trial is testing

Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants

Who this might be right for
Heavy Menstrual Bleeding
Cardioangiologisches Centrum Bethanien 84
Not applicableUnknownNCT03580577
What this trial is testing

Risk Factors and Outcomes of Acute Venous Thromboembolism in Cirrhotic

Who this might be right for
Liver CirrhosisVenous Thromboembolism
Assiut University 60
Large-scale testing (Phase 3)WithdrawnNCT00912483
What this trial is testing

Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients

Who this might be right for
Venous Thromboembolism
Azidus Brasil
Large-scale testing (Phase 3)Study completedNCT02369653
What this trial is testing

The Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase

Who this might be right for
LymphomaAcute Lymphoblastic Leukemia
Bristol-Myers Squibb 512
Not applicableStudy completedNCT01744431
What this trial is testing

Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients

Who this might be right for
Venous Thromboembolism
HaEmek Medical Center, Israel 400
Large-scale testing (Phase 3)Study completedNCT02585713
What this trial is testing

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Who this might be right for
Cerebral Vein ThrombosisDeep Vein ThrombosisGonadal Thrombosis+9 more
Academic and Community Cancer Research United 300
Not applicableStudy completedNCT06243510
What this trial is testing

Comparison of Apixaban Versus Enoxaparin

Who this might be right for
Bladder Cancer
Abramson Cancer Center at Penn Medicine 126
Large-scale testing (Phase 3)Looking for participantsNCT07410117
What this trial is testing

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

Who this might be right for
Cancer-Associated Thrombosis (CAT)
Regeneron Pharmaceuticals 1,120
Early research (Phase 1)Study completedNCT03919890
What this trial is testing

A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers

Who this might be right for
Venous Thromboembolism
Ono Pharmaceutical Co., Ltd. 72
Not applicableUnknownNCT00767559
What this trial is testing

Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery

Who this might be right for
Pulmonary Embolism
The New England Baptist Hospital 330
Not applicableActive Not RecruitingNCT01934725
What this trial is testing

Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome

Who this might be right for
Brain InfarctionIschemic StrokeThrombosis+1 more
SECRETO Study Consortium 1,200
Not applicableStudy completedNCT03535090
What this trial is testing

Coagulation After Intravenous Methylprednisolone Administration

Who this might be right for
Graves' DiseaseGraves OphthalmopathyBlood Coagulation+1 more
Piotr Miskiewicz 26
Next Page